Status:
RECRUITING
Screening for Islet Autoantibodies in the Israeli Paediatric General Population for Detection of Pre-symptomatic Type-1 Diabetes Mellitus
Lead Sponsor:
Rabin Medical Center
Collaborating Sponsors:
Juvenile Diabetes Research Foundation
Conditions:
Type1diabetes
Eligibility:
All Genders
9-5 years
Brief Summary
A national screening program for children aged 9 months-5 years that will be tested for the presence of islet autoantibodies.Up to 50,000 Children will be screened by their primary care physician all ...
Eligibility Criteria
Inclusion
- Informed consent obtained before any trial-related activities
- Children aged 9-months- 5 years at first screening.
Exclusion
- Known diagnosis of diabetes (Type 1 or other)
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT04834518
Start Date
April 1 2021
End Date
March 31 2027
Last Update
October 17 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Soroka Medical Center
Beersheba, Israel
2
Rambam Medical Center
Haifa, Israel
3
Hadassah medical Center
Jerusalem, Israel
4
Child Health Centers all over Israel (clalit Health Services)
Petah Tikva, Israel